查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1303928

核醫學市場：按產品、用途、類型和最終用戶 - 俄羅斯-烏克蘭衝突、高通貨膨脹的累積影響 - 2023-2030 年全球預測

Nuclear Medicine Market by Product, Application, Type, End-Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球核醫學市場預計將大幅成長，預計2023年將達到514618萬美元，年複合成長率為7.33%，2030年將達到845664萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球核醫學市場至關重要。通過檢驗業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球核醫學市場規模及預測是多少？

2. 在預測期內，COVID-19 對全球核醫學市場的抑制要素和影響是什麼？

3.在預測期內，全球核醫學市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球核醫學市場的競爭策略是什麼？

5. 全球核醫學市場的技術趨勢和法律規範是什麼？

6.全球核醫學市場主要廠商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球核醫學市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 全球癌症發病率和患病率正在上升
      • PET 和 SPECT 在診斷心臟和神經系統疾病中的使用增加
      • 國際組織支持核醫學的努力和認知
    • 抑制因素
      • 核醫學半衰期縮短
    • 機會
      • 治療診斷學在核醫學中日益普及
      • 持續的產品開發和專利技術進步
    • 任務
      • 新興國家缺乏核醫學知識、培訓和獲取途徑
      • 世界各地熟練的放射科醫生和醫生的數量有限
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 醫學市場：副產品

  • 診斷產品
    • 寵物
      • F-18
      • SR-82/RB-82
    • 斯派克特
      • GA-67
      • I-123
      • TC-99m
      • TL-201
  • 治療產品
    • 阿爾法發射器
    • BETA發射體
      • I-131
      • Lu-117
      • Re-186
      • SM-153
      • Y-90
    • 近距離放射治療
      • 銫131
      • 碘125
      • 銥192
      • 鈀103

第7章 醫學市場：按用途

  • 骨轉移
  • 心臟病學
  • 內分泌腫瘤
  • 淋巴瘤
  • 腫瘤學
  • 甲狀腺

第8章 醫學市場：按類型

  • 診斷
    • 正電子發射斷層掃描手術
    • SPECT程序
  • 治療性的
    • Alpha 發射器說明
    • Beta 發射器說明
    • 近距離放射治療程序

第9章 醫學市場：按最終用戶分類

  • 醫院和診斷中心
  • 調查機構

第10章 美洲核醫學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太核醫學市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲核醫學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-A339DAEFAF60

The Global Nuclear Medicine Market is forecasted to grow significantly, with a projected USD 5,146.18 million in 2023 at a CAGR of 7.33% and expected to reach a staggering USD 8,456.64 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Nuclear Medicine Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Nuclear Medicine Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Diagnostic Products and Therapeutic Products. The Diagnostic Products is further studied across PET and SPECT. The PET is further studied across F-18 and SR-82/RB-82. The SPECT is further studied across GA-67, I-123, TC-99m, and TL-201. The Therapeutic Products is further studied across Alpha Emitters, Beta Emitters, and Brachytherapy. The Beta Emitters is further studied across I-131, Lu-117, Re-186, SM-153, and Y-90. The Brachytherapy is further studied across Cesium-131, Iodine-125, Iridium-192, and Palladium-103. The Diagnostic Products commanded largest market share of 76.04% in 2022, followed by Therapeutic Products.

Based on Application, market is studied across Bone Metastasis, Cardiology, Endocrine Tumor, Lymphoma, Oncology, and Thyroid. The Oncology commanded largest market share of 23.93% in 2022, followed by Lymphoma.

Based on Type, market is studied across Diagnostic and Therapeutic. The Diagnostic is further studied across PET Procedures and SPECT Procedures. The Therapeutic is further studied across Alpha Emitter Procedures, Beta Emitter Procedures, and Brachytherapy Procedures. The Diagnostic commanded largest market share of 77.34% in 2022, followed by Therapeutic.

Based on End-Users, market is studied across Hospitals & Diagnostic Centers and Research institutes. The Hospitals & Diagnostic Centers commanded largest market share of 91.85% in 2022, followed by Research institutes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.48% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Nuclear Medicine Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Nuclear Medicine Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nuclear Medicine Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nuclear Medicine Market?

4. What is the competitive strategic window for opportunities in the Global Nuclear Medicine Market?

5. What are the technology trends and regulatory frameworks in the Global Nuclear Medicine Market?

6. What is the market share of the leading vendors in the Global Nuclear Medicine Market?

7. What modes and strategic moves are considered suitable for entering the Global Nuclear Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Nuclear Medicine Market, by Product, 2022 vs 2030
  • 4.3. Nuclear Medicine Market, by Application, 2022 vs 2030
  • 4.4. Nuclear Medicine Market, by Type, 2022 vs 2030
  • 4.5. Nuclear Medicine Market, by End-Users, 2022 vs 2030
  • 4.6. Nuclear Medicine Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Incidence and Prevalence of Cancer Worldwide
      • 5.1.1.2. Increasing Use of PET and SPECT to Diagnose Heart disease and Neurological Disorders
      • 5.1.1.3. International Organizations' Initiatives and Awareness Supporting Nuclear Medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Shorter Half-Life of Nuclear Medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Popularity of Theranostics in Nuclear Medicine
      • 5.1.3.2. Continuous Product Developments and Advancements in Patented Technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Knowledge, Training, and Availability of Nuclear Medicine in Developing Countries
      • 5.1.4.2. Limited Availability of Skilled Radiologists and Practitioners Worldwide
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Nuclear Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostic Products
    • 6.2.1. PET
      • 6.2.1.1. F-18
      • 6.2.1.2. SR-82/RB-82
    • 6.2.2. SPECT
      • 6.2.2.1. GA-67
      • 6.2.2.2. I-123
      • 6.2.2.3. TC-99m
      • 6.2.2.4. TL-201
  • 6.3. Therapeutic Products
    • 6.3.1. Alpha Emitters
    • 6.3.2. Beta Emitters
      • 6.3.2.1. I-131
      • 6.3.2.2. Lu-117
      • 6.3.2.3. Re-186
      • 6.3.2.4. SM-153
      • 6.3.2.5. Y-90
    • 6.3.3. Brachytherapy
      • 6.3.3.1. Cesium-131
      • 6.3.3.2. Iodine-125
      • 6.3.3.3. Iridium-192
      • 6.3.3.4. Palladium-103

7. Nuclear Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Bone Metastasis
  • 7.3. Cardiology
  • 7.4. Endocrine Tumor
  • 7.5. Lymphoma
  • 7.6. Oncology
  • 7.7. Thyroid

8. Nuclear Medicine Market, by Type

  • 8.1. Introduction
  • 8.2. Diagnostic
    • 8.2.1. PET Procedures
    • 8.2.2. SPECT Procedures
  • 8.3. Therapeutic
    • 8.3.1. Alpha Emitter Procedures
    • 8.3.2. Beta Emitter Procedures
    • 8.3.3. Brachytherapy Procedures

9. Nuclear Medicine Market, by End-Users

  • 9.1. Introduction
  • 9.2. Hospitals & Diagnostic Centers
  • 9.3. Research institutes

10. Americas Nuclear Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Nuclear Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Nuclear Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NUCLEAR MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEAR MEDICINE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 7. NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
  • FIGURE 8. NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. NUCLEAR MEDICINE MARKET DYNAMICS
  • FIGURE 10. NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NUCLEAR MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 6. NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 8. NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 12. NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 18. NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 21. NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 28. NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 42. NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 46. NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 176. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 212. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 235. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 258. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 259. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 270. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 271. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 272. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 282. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 283. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 297. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 298. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 299. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 303. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 304. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 307. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 308. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 309. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 311. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 313. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 315. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 316. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 319. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 320. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 321. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 322. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 323. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 324. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 325. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 326. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 327. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 328. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 329. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 330. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 331. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 332. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 333. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 334. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 335. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 336. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 337. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 338. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 339. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 340. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 341. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 342. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 343. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 344. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 345. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 346. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 347. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 348. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 349. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 350. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 351. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 352. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 353. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 354. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 355. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 356. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 357. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 358. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 359. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
  • TABLE 360. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
  • TABLE 361. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 362. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 363. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 364. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 365. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 366. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
  • TABLE 367. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030